IDT Australia Limited (ASX:IDT)
Australia · Delayed Price · Currency is AUD 0.0440
-0.0010 (-2.22%)
Oct 1, 2026, 1:27 PM AEST
IDT Australia Revenue
In the fiscal year ending June 30, 2026, IDT Australia had annual revenue of 20.38M AUD with 3.12% growth. IDT Australia had revenue of 10.66M in the half year ending June 30, 2026, with 28.58% growth.
Revenue
20.38M
Revenue Growth
+3.12%
P/S Ratio
0.92
Revenue / Employee
203.81K
Employees
100
Market Cap
18.80M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2026 | 20.38M | 616.00K | 3.12% |
| Jun 30, 2025 | 19.77M | 5.75M | 40.99% |
| Jun 30, 2024 | 14.02M | 7.03M | 100.67% |
| Jun 30, 2023 | 6.99M | -5.14M | -42.41% |
| Jun 30, 2022 | 12.13M | -4.80M | -28.34% |
| Jun 30, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Vitura Health | 131.16M |
| Little Green Pharma | 75.50M |
| Medical Developments International | 42.57M |
| ECS Botanics Holdings | 21.02M |
| Epsilon Healthcare | 13.58M |
| Peak Processing | 12.51M |
| Cann Group | 9.65M |
| Syntara | 6.93M |